Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Prescott

Showing results (541-550 of 563) with videos related to

Pageof 57
Sort By:
Circulation. Heart Failure|October 4, 2014
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696Pardeep S Jhund, Brian L Claggett, Adriaan A Voors, et al.
Circulation. Heart Failure|February 18, 2020
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection FractionRasmus Rørth, Pardeep S Jhund, Mehmet B Yilmaz, et al.
ESC Heart Failure|May 12, 2025
Association between NT-proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA-HF and PARADIGM-HFRobert Shaddy, Jianjian Gong, Tania Garito, et al.
European Journal of Heart Failure|January 31, 2017
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trialBiniyam G Demissei, Gad Cotter, Margaret F Prescott, et al.
European Journal of Heart Failure|September 4, 2015
Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF studyGad Cotter, Adriaan A Voors, Margaret F Prescott, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 28, 2016
Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHFLicette C Y Liu, Adriaan A Voors, John R Teerlink, et al.
JACC. Heart Failure|April 16, 2018
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart FailureKevin Damman, Mauro Gori, Brian Claggett, et al.
European Journal of Heart Failure|July 4, 2023
Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartanPeder L Myhre, Yuxi Liu, Ian J Kulac, et al.
European Journal of Heart Failure|September 4, 2015
Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF studyG Michael Felker, Robert J Mentz, John R Teerlink, et al.
Journal of the American Heart Association|September 23, 2020
NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes MellitusMarcus V B Malachias, Pardeep S Jhund, Brian L Claggett, et al.
Pageof 57

Showing results (541-550 of 563) with videos related to

Sort By:
Pageof 57
Circulation. Heart Failure|October 4, 2014
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696Pardeep S Jhund, Brian L Claggett, Adriaan A Voors, et al.
Circulation. Heart Failure|February 18, 2020
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection FractionRasmus Rørth, Pardeep S Jhund, Mehmet B Yilmaz, et al.
ESC Heart Failure|May 12, 2025
Association between NT-proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA-HF and PARADIGM-HFRobert Shaddy, Jianjian Gong, Tania Garito, et al.
European Journal of Heart Failure|January 31, 2017
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trialBiniyam G Demissei, Gad Cotter, Margaret F Prescott, et al.
European Journal of Heart Failure|September 4, 2015
Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF studyGad Cotter, Adriaan A Voors, Margaret F Prescott, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 28, 2016
Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHFLicette C Y Liu, Adriaan A Voors, John R Teerlink, et al.
JACC. Heart Failure|April 16, 2018
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart FailureKevin Damman, Mauro Gori, Brian Claggett, et al.
European Journal of Heart Failure|July 4, 2023
Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartanPeder L Myhre, Yuxi Liu, Ian J Kulac, et al.
European Journal of Heart Failure|September 4, 2015
Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF studyG Michael Felker, Robert J Mentz, John R Teerlink, et al.
Journal of the American Heart Association|September 23, 2020
NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes MellitusMarcus V B Malachias, Pardeep S Jhund, Brian L Claggett, et al.
Pageof 57